US

Imbed Biosciences reels in $4 mln

Madison, Wisconsin-based Imbed Biosciences Inc, a biotech company focused on developing advanced therapies for burns, chronic ulcers and surgical wounds, has raised $4 million in funding. Formidable Asset Management led the round with participation from other investors that included WISC Partners.

Mooala rallies $8.3 mln

Dallas-based Mooala, a maker of organic, dairy-free beverages and creamers, has raised $8.3 million in Series A equity financing. Sweat Equities led the round with participation from other backers that included M3 Ventures.

Shape Therapeutics nets $35.5 mln Series A

Seattle-based Shape Therapeutics Inc, a developer of a RNA and protein targeting platform focused on curing human diseases, has secured $35.5 million in Series A financing. New Enterprise Associates led the round participation from CureDuchenne Ventures.

Kenzie Academy scores $100 mln

Indianapolis-based Kenzie Academy, an education startup, has raised $100 million in financing. The investor was Community Investment Management.

FamePick fetches $4.6 mln Series A

Redwood City, California-based FamePick, a platform that helps business creators grow their personal brand, has raised $4.6 million in Series A funding. The investors included InterVest, Mirae Asset Venture, Aju IB Investment and DVP.

Eight Sleep picks up $40 mln

Eight Sleep, a sleep fitness company, has secured $40 million in funding. Founders Fund led the round with participation from other investors that included Craft Ventures, Khosla Ventures, Y Combinator and 8VC.

Digital banking platform HMBradley snags $3.5 mln seed

HMBradley, a new digital banking platform, has raised $3.5 million in seed financing. Accomplice Ventures and Walkabout Ventures led the round with participation from other investors that included Mucker Capital, Index Ventures and HVF Labs.

Acticor Biotech grabs funding

Paris-based Acticor Biotech, a clinical stage biotechnology focused on thrombotic diseases, has raised 7 million euros in funding. Go Capital led the round with participation from return backers Newton BioCapital, CapDecisif Management and Anaxago.

Arweave takes in $5 mln

Arweave, a new blockchain protocol, has raised $5 million in funding. The lead backer was a16z crypto. Other participating investors included Multicoin Capital and Union Square Ventures.

AstraZeneca and China International Capital to launch $1 bln China biotech venture fund: Bloomberg

U.S. drugmaker AstraZeneca and China International Capital Corp are teaming up to launch a $1 billion China-focused biotech venture fund, reported Bloomberg. The news outlet added that AstraZeneca will not be a majority investor, according to CEO Pascal Soriot.